Related Experiment Videos

Enhancement of polymorphonuclear leukocyte-mediated tumor cytotoxicity by serum factor(s)

A Araki1, T Inoue, S Kimura

  • 1Department of Parasitology, Yamagata University, School of Medicine.

Insights

Fetal calf serum enhances tumor cell killing by mouse polymorphonuclear leukocytes (PMN) when stimulated by beta-1,3-D-glucan (TAK). This serum factor is heat-stable and active in various animal sera, boosting PMN

Area of Science:

  • Immunology
  • Biochemistry

Background:

  • Beta-1,3-D-glucan from Alcaligenes faecalis (TAK) is known to promote tumor cytolysis via mouse polymorphonuclear leukocytes (PMN).
  • The role of serum factors in modulating this PMN-mediated tumoricidal activity requires further investigation.

Purpose of the Study:

  • To investigate the effect of serum on mouse PMN-mediated tumor cytolysis induced by TAK.
  • To characterize the serum-derived factors responsible for enhancing PMN tumoricidal activity.

Main Methods:

  • Tumor cytolysis assays using mouse PMN and TAK, with varying concentrations of fetal calf serum (FCS).
  • Fractionation of serum components using Superose 6 chromatography.
  • Stability assays of serum factors under heat and low pH conditions.
  • Measurement of hydrogen peroxide production by PMN.

Main Results:

  • Fetal calf serum significantly enhanced PMN-mediated tumor cytolysis in a dose-dependent manner.
  • Serum from various species (horse, mouse, rat) also demonstrated enhancing activity.
  • The enhancing factor was found to be heat-stable (60°C, 30 min) and stable at low pH (pH 2), with a peak activity around 170 kD.
  • TAK-stimulated mouse PMN showed increased hydrogen peroxide production in the presence of FCS.

Conclusions:

  • Serum contains factors that potentiate beta-1,3-D-glucan-induced tumor cytolysis by mouse PMN.
  • These serum factors are robust, suggesting potential therapeutic applications in cancer immunotherapy.
  • Further characterization of these factors could lead to novel strategies for enhancing anti-tumor immune responses.

Related Concept Videos